Tejano, Rolando S.
HRN: 26-40-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/18/2024
12/25/2024
IV
2.25
Q12h
Hepatitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes